Home>Topics>>Express Scripts scales back coverage of compounded meds

Express Scripts scales back coverage of compounded meds

SeekingAlpha.com: SA Currents

Thu, 3 Jul 2014

Saying that most custom-mixed medicines are either ineffective or overpriced, pharmacy benefit manager Express Scripts ( ESRX +0.6% ) plans to drop coverage for 1,000 drug ingredients found in compounded meds. The company states that the move will reduce employers' spending on compounded ...

Related Videos

  1. Morningstar Minute: 3 Pillars to Express Scripts' Wide Moat

    Tue, 4 Mar 2014

    Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.

  2. Three Frontrunners for CEO of the Year 2012

    Thu, 1 Nov 2012

    CEOs from three moat-worthy firms are in the running for this year's award.

  3. Pharmacy Benefit Managers Weigh on Drug Retailers

    Tue, 8 May 2012

    The increasing power of PBM's like Express Scripts is putting pressure on drugstores, according to Morningstar's Matt Coffina.

  4. 4 Stocks to Watch in 2013

    Thu, 10 Jan 2013

    Several names have great dividend-growth potential, while industry tailwinds will be a boon for another, according to Sanibel Captiva's Pat Dorsey.

Content Partners